At a glance
ClinicalIndex Comparison RecordN/ACompleted· 22 enrolled
Drug / intervention
Elevated night pacing on +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
REmodeling the Left Ventricle With Atrial Modulated Pacing
In Brief
A clinical study evaluating Elevated night pacing on and Elevated night pacing off for Heart Failure. Completed, enrolled 22 participants across 10 sites.
Detailed Summary
New therapy tested in heart failure with preserved ejection fraction (HFpEF) patients with approved indications for pacing to determine if elevated pacing therapy is tolerated and whether there is a signal for efficacy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 2017
Enrollment StartSep 2017
Primary CompletionMar 2021
TodayJul 2026
First PostedJul 6, 2017
Enrollment StartSep 15, 2017
Primary CompletionMar 15, 2021
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 9.0 years ago
Interventions
Elevated night pacing ondevice
Device will be programmed to 100 beats per minute (bpm) for five hours during normal sleep times
Elevated night pacing offdevice
Device will be programmed to normal lower rates